Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
William CS Cho. (2012) MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opinion on Therapeutic Targets 16:8, pages 747-759.
Read now
Read now
Articles from other publishers (13)
Kai K. Kummer. 2020. Reference Module in Neuroscience and Biobehavioral Psychology. Reference Module in Neuroscience and Biobehavioral Psychology.
Kai K. Kummer, Theodora Kalpachidou & Michaela Kress. 2020. The Senses: A Comprehensive Reference. The Senses: A Comprehensive Reference
410
443
.
Jialin Song, Yuanming Ouyang, Junyi Che, Xiaoming Li, Yi Zhao, Kejia Yang, Xiaotian Zhao, Yinghui Chen, Cunyi Fan & Weien Yuan. (2017) Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases. Frontiers in Immunology 8.
Crossref
Crossref
Yasuto Kinose, Kenjiro Sawada, Koji Nakamura, Ikuko Sawada, Aska Toda, Erika Nakatsuka, Kae Hashimoto, Seiji Mabuchi, Kazuhiro Takahashi, Hirohisa Kurachi, Ernst Lengyel & Tadashi Kimura. (2015) The hypoxia-related microRNA miR-199a-3p displays tumor suppressor functions in ovarian carcinoma. Oncotarget 6:13, pages 11342-11356.
Crossref
Crossref
Jessian L. Munoz, Vivian Rodriguez-Cruz, Shakti H. Ramkissoon, Keith L. Ligon, Steven J. Greco & Pranela Rameshwar. (2015) Temozolomide resistance in glioblastoma occurs by miRNA-9-targeted PTCH1, independent of sonic hedgehog level. Oncotarget 6:2, pages 1190-1201.
Crossref
Crossref
Yongming Xu, Xin Zhang, Shaofeng Pu, Junzhen Wu, Yingying Lv & Dongping Du. (2014) Circulating microRNA expression profile: a novel potential predictor for chronic nervous lesions. Acta Biochimica et Biophysica Sinica 46:11, pages 942-949.
Crossref
Crossref
Yuan Li, Chunli Liang, Haizhong Ma, Qian Zhao, Ying Lu, Zhendong Xiang, Li Li, Jie Qin, Yihan Chen, William Cho, Richard Pestell, Li Liang & Zuoren Yu. (2014) miR-221/222 Promotes S-Phase Entry and Cellular Migration in Control of Basal-Like Breast Cancer. Molecules 19:6, pages 7122-7137.
Crossref
Crossref
Qifeng Li, Ke Shen, Yang Zhao, Chenkai Ma, Jianwen Liu & Jie Ma. (2013) MiR-92b inhibitor promoted glioma cell apoptosis via targeting DKK3 and blocking the Wnt/beta-catenin signaling pathway. Journal of Translational Medicine 11:1.
Crossref
Crossref
Yu Zhang, Zaijie Wang & Richard A. Gemeinhart. (2013) Progress in microRNA delivery. Journal of Controlled Release 172:3, pages 962-974.
Crossref
Crossref
Kay Ka-Wai Li, Jesse Chung-Sean Pang, Kin-Mang Lau, Liangfu Zhou, Ying Mao, Yin Wang, Wai-Sang Poon & Ho-Keung Ng. (2013) MiR-383 is Downregulated in Medulloblastoma and Targets Peroxiredoxin 3 (PRDX3). Brain Pathology 23:4, pages 413-425.
Crossref
Crossref
Paride Pelucchi, Valeria Tria, Valentina Martino, Davood Sabour, Giovanni Bertalot, Stefano Molgora, Mira Palizban, Martin Götte, Ileana Zucchi & Rolland Reinbold. (2013) A Versatile Tool for Stable Inhibition of microRNA Activity. Biology 2:3, pages 861-871.
Crossref
Crossref
Chifumi Ohyagi-Hara, Kenjiro Sawada, Shoji Kamiura, Yasuhiko Tomita, Aki Isobe, Kae Hashimoto, Yasuto Kinose, Seiji Mabuchi, Takeshi Hisamatsu, Toshifumi Takahashi, Keiichi Kumasawa, Shigenori Nagata, Ken-ichirou Morishige, Ernst Lengyel, Hirohisa Kurachi & Tadashi Kimura. (2013) miR-92a Inhibits Peritoneal Dissemination of Ovarian Cancer Cells by Inhibiting Integrin α5 Expression. The American Journal of Pathology 182:5, pages 1876-1889.
Crossref
Crossref
Yuchen Liu, Yonghua Han, Hu Zhang, Liping Nie, Zhimao Jiang, Pingping Fa, Yaoting Gui & Zhiming Cai. (2012) Synthetic miRNA-Mowers Targeting miR-183-96-182 Cluster or miR-210 Inhibit Growth and Migration and Induce Apoptosis in Bladder Cancer Cells. PLoS ONE 7:12, pages e52280.
Crossref
Crossref